HemCon Medical Technologies, Inc.

HemCon Medical Technologies, Inc.
Share
GuardIVa™ Hemostatic Antimicrobial IV Dressing is a complete IV site care solution that combines the powerful antimicrobial protection of chlorhexidine gluconate (CHG), a well-known antiseptic agent with broad spectrum antimicrobial and antifungal activity, with the unique properties of HemCon’s proprietary hemostatic oxidized cellulose in a sponge dressing.

Tricol International Group Limited Completes Asset Acquisition of HemCon Medical Technologies Inc. Global microfiber expert to stabilize and focus growth of Oregon based advanced wound care company. Tricol International Group Ltd., a Marshall Islands based company and global leader in microfiber products along with its 100% wholly owned Oregon...

Global microfiber expert to stabilize and focus growth of Oregon based advanced wound care company
Tricol International Group Ltd., a Marshall Islands based company and global leader in microfiber products along with its 100% wholly owned Oregon based subsidiary Tricol Biomedical, Inc. announced today that it has acquired HemCon Medical...

HemCon Medical Technologies, Inc.

 •  January 15, 2016

Company to be acquired and reorganized under new ownership
HemCon Medical Technologies, Inc. (“HemCon”) announced today that it is transitioning to new ownership though a Court protected transaction. HemCon is an advanced wound care company focused on development, innovation and marketing of innovative wound care technologies for hemostasis, wound...

TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) a health and wellness company that targets opportunities in the advanced wound care marketplace, announced today that its Portland, Oregon based wholly owned independent subsidiary HemCon Medical Technologies, Inc. (HemCon) has been awarded funding from the National Institutes of Health (NIH) to ...